{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:51:13Z","timestamp":1792144273679,"version":"4.4.0"},"reference-count":196,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T00:00:00Z","timestamp":1666051200000},"content-version":"am","delay-in-days":351,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R15 AG051132-01"],"award-info":[{"award-number":["R15 AG051132-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Gerontology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.exger.2021.111585","type":"journal-article","created":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T07:19:17Z","timestamp":1633763957000},"page":"111585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Parkinson's disease and microRNAs - Lessons from model organisms and human studies"],"prefix":"10.1016","volume":"155","author":[{"given":"Brian","family":"Evans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"IV","given":"Howard A.","family":"Furlong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"de Lencastre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exger.2021.111585_bb0005","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.tcb.2012.08.013","article-title":"MicroRNAs and neurodegeneration: role and impact","volume":"23","author":"Abe","year":"2013","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.exger.2021.111585_bb0010","doi-asserted-by":"crossref","first-page":"872","DOI":"10.18632\/oncotarget.1825","article-title":"miR-34: from bench to bedside","volume":"5","author":"Agostini","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.exger.2021.111585_bb0015","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3390\/cells8060565","article-title":"Autophagy in synucleinopathy: the overwhelmed and defective machinery","volume":"8","author":"Arotcarena","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.exger.2021.111585_bb0020","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neures.2013.09.003","article-title":"Trasferrin receptor 2 gene regulation by MicroRNA 221 in SH-SY5Y cells treated with MPP+ as Parkinson\u2019s disease cellular model","volume":"77","author":"Asci","year":"2013","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.exger.2021.111585_bb0025","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s12031-009-9325-1","article-title":"Global microRNA expression profiling of Caenorhabditis elegans Parkinson\u2019s disease models","volume":"41","author":"Asikainen","year":"2010","journal-title":"Journal of molecular neuroscience: MN"},{"key":"10.1016\/j.exger.2021.111585_bb0030","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.biopha.2015.07.034","article-title":"Schisandrin B shows neuroprotective effect in 6-OHDA-induced Parkinson\u2019s disease via inhibiting the negative modulation of miR-34a on Nrf2 pathway","volume":"75","author":"Ba","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.exger.2021.111585_bb0035","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10571-019-00751-y","article-title":"Specific signatures of serum miRNAs as potential biomarkers to discriminate clinically similar neurodegenerative and vascular-related diseases","volume":"40","author":"Barbagallo","year":"2020","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.exger.2021.111585_bb0040","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.exger.2021.111585_bb0045","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cell.2018.03.006","article-title":"Metazoan MicroRNAs","volume":"173","author":"Bartel","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.exger.2021.111585_bb0050","doi-asserted-by":"crossref","DOI":"10.3791\/835","article-title":"Application of a C. elegans dopamine neuron degeneration assay for the validation of potential Parkinson\u2019s disease genes","author":"Berkowitz","year":"2008","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.exger.2021.111585_bb0055","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.4161\/auto.25884","article-title":"The TOMM machinery is a molecular switch in PINK1 and PARK2\/PARKIN-dependent mitochondrial clearance","volume":"9","author":"Bertolin","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.exger.2021.111585_bb0060","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1126\/science.1115596","article-title":"A developmental timing MicroRNA and its target regulate life span in C. elegans","volume":"310","author":"Boehm","year":"2005","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.exger.2021.111585_bb0065","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.cmet.2012.02.014","article-title":"The C. elegans MicroRNA mir-71 acts in neurons to promote germline-mediated longevity through regulation of DAF-16\/FOXO","volume":"15","author":"Boulias","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.exger.2021.111585_bb0070","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1128\/MCB.25.3.1025-1040.2005","article-title":"Inhibition of macroautophagy triggers Apoptosis\u2020","volume":"25","author":"Boya","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.exger.2021.111585_bb0075","doi-asserted-by":"crossref","first-page":"17764","DOI":"10.1073\/pnas.1920404117","article-title":"The biochemical basis for the cooperative action of microRNAs","volume":"117","author":"Briskin","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.exger.2021.111585_bb0080","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3892\/ijo.2015.3308","article-title":"High levels of apoptosis are induced in human glioma cell lines by co-administration of peptide nucleic acids targeting miR-221 and miR-222","volume":"48","author":"Brognara","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.exger.2021.111585_bb0085","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1111\/j.1742-4658.2010.07643.x","article-title":"Nuclear factor TDP-43 can affect selected microRNA levels","volume":"277","author":"Buratti","year":"2010","journal-title":"FEBS J."},{"key":"10.1016\/j.exger.2021.111585_bb0090","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1126\/science.1195227","article-title":"\u03b1-synuclein promotes SNARE-complex assembly in vivo and in vitro","volume":"329","author":"Burr\u00e9","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.exger.2021.111585_bb0095","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.cellbio.23.090506.123406","article-title":"microRNA functions","volume":"23","author":"Bushati","year":"2007","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.exger.2021.111585_bb0100","doi-asserted-by":"crossref","DOI":"10.18632\/aging.102649","article-title":"Up-regulation of microRNA-375 ameliorates the damage of dopaminergic neurons, reduces oxidative stress and inflammation in Parkinson\u2019s disease by inhibiting SP1","volume":"12","author":"Cai","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.exger.2021.111585_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215277","article-title":"Necrosis, apoptosis, necroptosis, three modes of action of dopaminergic neuron neurotoxins","volume":"14","author":"Callizot","year":"2019","journal-title":"Plos One"},{"key":"10.1016\/j.exger.2021.111585_bb0110","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1126\/science.8303295","article-title":"Green fluorescent protein as a marker for gene expression","volume":"263","author":"Chalfie","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.exger.2021.111585_bb0115","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/biology8020038","article-title":"Mitochondrial dysfunction in Parkinson\u2019s Disease\u2014Cause or Consequence?","volume":"8","author":"Chen","year":"2019","journal-title":"Biology"},{"key":"10.1016\/j.exger.2021.111585_bb0120","doi-asserted-by":"crossref","first-page":"e2813","DOI":"10.1038\/cddis.2017.214","article-title":"Dicer and microRNAs protect adult dopamine neurons","volume":"8","author":"Chmielarz","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.exger.2021.111585_bb0125","doi-asserted-by":"crossref","first-page":"12725","DOI":"10.1523\/JNEUROSCI.0985-14.2014","article-title":"MicroRNA-7 protects against 1-methyl-4-phenylpyridinium-induced cell death by targeting RelA","volume":"34","author":"Choi","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.exger.2021.111585_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202770","article-title":"Charting the onset of parkinson-like motor and non-motor symptoms in nonhuman primate model of Parkinson\u2019s disease","volume":"13","author":"Choudhury","year":"2018","journal-title":"Plos One"},{"key":"10.1016\/j.exger.2021.111585_bb0135","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.biomaterials.2015.12.021","article-title":"Intravenous administration of brain-targeted stable nucleic acid lipid particles alleviates Machado-Joseph disease neurological phenotype","volume":"82","author":"Concei\u00e7\u00e3o","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.exger.2021.111585_bb0140","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/3311","article-title":"Accelerated in vitro fibril formation by a mutant \u03b1-synuclein linked to early-onset parkinson disease","volume":"4","author":"Conway","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.exger.2021.111585_bb0145","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.bbadis.2009.01.012","article-title":"A critical evaluation of the ubiquitin\u2013proteasome system in Parkinson\u2019s disease","volume":"1792","author":"Cook","year":"2009","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.exger.2021.111585_bb0150","doi-asserted-by":"crossref","first-page":"15022","DOI":"10.1038\/npjparkd.2015.22","article-title":"Delaying aging is neuroprotective in Parkinson\u2019s disease: a genetic analysis in C. elegans models","volume":"1","author":"Cooper","year":"2015","journal-title":"NPJ Parkinson\u2019s Dis."},{"key":"10.1016\/j.exger.2021.111585_bb0155","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1534\/genetics.115.176099","article-title":"A transparent window into biology: a primer on Caenorhabditis elegans","volume":"200","author":"Corsi","year":"2015","journal-title":"Genetics"},{"key":"10.1016\/j.exger.2021.111585_bb0160","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.nbd.2015.02.005","article-title":"\u03b1-synuclein-mediated inhibition of ATF6 processing into COPII vesicles disrupts UPR signaling in Parkinson\u2019s disease","volume":"76","author":"Credle","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.exger.2021.111585_bb0165","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1002\/glia.23645","article-title":"Glial HMOX1 expression promotes central and peripheral \u03b1-synuclein dysregulation and pathogenicity in parkinsonian mice","volume":"67","author":"Cressatti","year":"2019","journal-title":"Glia"},{"key":"10.1016\/j.exger.2021.111585_bb0170","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/mds.27935","article-title":"Salivary microR-153 and microR-223 levels as potential diagnostic biomarkers of idiopathic Parkinson\u2019s disease","volume":"35","author":"Cressatti","year":"2020","journal-title":"Mov.Disord."},{"key":"10.1016\/j.exger.2021.111585_bb0175","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1126\/science.1101738","article-title":"Impaired degradation of mutant \u03b1-synuclein by chaperone-mediated autophagy","volume":"305","author":"Cuervo","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.exger.2021.111585_bb0180","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u2019s disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.exger.2021.111585_bb0185","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1087753","article-title":"Molecular pathways of neurodegeneration in Parkinson\u2019s disease","volume":"302","author":"Dawson","year":"2003","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.exger.2021.111585_bb0190","article-title":"Measuring motor coordination in mice","volume":"2609","author":"Deacon","year":"2013","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.exger.2021.111585_bb0195","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.gene.2018.04.010","article-title":"Differential expression of miR-34a, miR-141, and miR-9 in MPP+-treated differentiated PC12 cells as a model of Parkinson\u2019s disease","volume":"662","author":"Delavar","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.exger.2021.111585_bb0200","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/jnc.12437","article-title":"Alternative polyadenylation and miR-34 family members regulate tau expression","volume":"127","author":"Dickson","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.exger.2021.111585_bb0205","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41419-019-2078-z","article-title":"Ablation of RIP3 protects from dopaminergic neurodegeneration in experimental Parkinson\u2019s disease","volume":"10","author":"Dion\u00edsio","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.exger.2021.111585_bb0210","doi-asserted-by":"crossref","first-page":"12726","DOI":"10.1074\/jbc.M109.086827","article-title":"Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153","volume":"285","author":"Doxakis","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exger.2021.111585_bb0215","first-page":"1","article-title":"Understanding microRNAs in neurodegeneration","author":"Eacker","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.exger.2021.111585_bb0220","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1038\/sj.onc.1209909","article-title":"Principles and effects of MicroRNA-mediated post-transcriptional gene regulation","volume":"25","author":"Engels","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.exger.2021.111585_bb0225","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00401-017-1787-6","article-title":"Regional levels of physiological \u03b1-synuclein are directly associated with lewy body pathology","volume":"135","author":"Erskine","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.exger.2021.111585_bb0230","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrc1840","article-title":"Oncomirs - microRNAs with a role in cancer","volume":"6","author":"Esquela-Kerscher","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.exger.2021.111585_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2003.tb07458.x","article-title":"Description of Parkinson\u2019s disease as a clinical syndrome","volume":"991","author":"Fahn","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.exger.2021.111585_bb0240","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/jnc.13618","article-title":"Cellular models for Parkinson\u2019s disease","volume":"139","author":"Falkenburger","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.exger.2021.111585_bb0245","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1046\/j.1471-4159.1998.70010268.x","article-title":"Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay","volume":"70","author":"Floor","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.exger.2021.111585_bb0250","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s004060050101","article-title":"Clinical features of Alzheimer\u2019s disease","volume":"249","author":"F\u00f6rstl","year":"1999","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.exger.2021.111585_bb0255","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3389\/fncel.2014.00182","article-title":"miR-7 and miR-153 protect neurons against MPP(+)-induced cell death via upregulation of mTOR pathway","volume":"8","author":"Fragkouli","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.exger.2021.111585_bb0260","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/genetics\/118.1.75","article-title":"A mutation in the age-1 gene in Caenorhabditis elegans lengthens life and reduces hermaphrodite fertility","volume":"118","author":"Friedman","year":"1988","journal-title":"Genetics"},{"key":"10.1016\/j.exger.2021.111585_bb0265","doi-asserted-by":"crossref","first-page":"e103130","DOI":"10.1371\/journal.pone.0103130","article-title":"Gene silencing mediated by endogenous MicroRNAs under heat stress conditions in mammalian cells","volume":"9","author":"Fukuoka","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.exger.2021.111585_bb0270","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3390\/brainsci9040073","article-title":"Found in translation: the utility of C. elegans Alpha-synuclein models of Parkinson\u2019s disease","volume":"9","author":"Gaeta","year":"2019","journal-title":"Brain Sci."},{"key":"10.1016\/j.exger.2021.111585_bb0275","doi-asserted-by":"crossref","first-page":"13450","DOI":"10.1073\/pnas.96.23.13450","article-title":"Axon pathology in Parkinson\u2019s disease and lewy body dementia hippocampus contains \u03b1-, \u03b2-, and \u03b3-synuclein","volume":"96","author":"Galvin","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exger.2021.111585_bb0280","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/s41419-019-2091-2","article-title":"Mitochondrial damage by \u03b1-synuclein causes cell death in human dopaminergic neurons","volume":"10","author":"Ganjam","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.exger.2021.111585_bb0285","doi-asserted-by":"crossref","first-page":"11364","DOI":"10.1073\/pnas.0802076105","article-title":"Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress","volume":"105","author":"Gautier","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.exger.2021.111585_bb0290","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41580-018-0045-7","article-title":"Regulation of microRNA function in animals","volume":"20","author":"Gebert","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.exger.2021.111585_bb0295","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nature09191","article-title":"Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression","volume":"466","author":"Gehrke","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.exger.2021.111585_bb0300","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/dvdy.22231","article-title":"C. elegans as a model organism to investigate molecular pathways involved with Parkinson\u2019s disease","volume":"239","author":"Harrington","year":"2010","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.exger.2021.111585_bb0305","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1073\/pnas.0710263105","article-title":"Loss of microRNA cluster miR-29a\/b-1 in sporadic Alzheimer\u2019s disease correlates with increased BACE1\/beta-secretase expression","volume":"105","author":"H\u00e9bert","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exger.2021.111585_bb0310","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1007\/s11064-018-2638-0","article-title":"Signature of aberrantly expressed microRNAs in the Striatum of rotenone-induced Parkinsonian rats","volume":"43","author":"Horst","year":"2018","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.exger.2021.111585_bb0315","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.3389\/fnagi.2016.00036","article-title":"MicroRNA profiles in Parkinson\u2019s disease prefrontal cortex","volume":"8","author":"Hoss","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.exger.2021.111585_bb0320","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41419-019-1809-5","article-title":"miR-425 deficiency promotes necroptosis and dopaminergic neurodegeneration in Parkinson\u2019s disease","volume":"10","author":"Hu","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.exger.2021.111585_bb0325","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1038\/emboj.2008.163","article-title":"Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in drosophila","volume":"27","author":"Imai","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.exger.2021.111585_bb0330","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1093\/hmg\/ddx179","article-title":"Vps35 in cooperation with LRRK2 regulates synaptic vesicle endocytosis through the endosomal pathway in drosophila","volume":"26","author":"Inoshita","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.exger.2021.111585_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040028","article-title":"Novel MicroRNAs differentially expressed during aging in the mouse brain","volume":"7","author":"Inukai","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.exger.2021.111585_bb0340","doi-asserted-by":"crossref","first-page":"36766","DOI":"10.1038\/srep36766","article-title":"MicroRNA mir-34 provides robustness to environmental stress response via the DAF-16 network in C. elegans","volume":"6","author":"Isik","year":"2016","journal-title":"Sci. Rep.-UK"},{"key":"10.1016\/j.exger.2021.111585_bb0345","series-title":"MicroRNA mir-34 Provides Robustness to Environmental Stress Response via the DAF-16 Network in C. elegans","first-page":"1","author":"Isik","year":"2016"},{"key":"10.1016\/j.exger.2021.111585_bb0350","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson\u2019s disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.exger.2021.111585_bb0355","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/toxsci\/kfaa066","article-title":"Coordinated action of miR-146a and parkin gene regulate rotenone-induced neurodegeneration","volume":"176","author":"Jauhari","year":"2020","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.exger.2021.111585_bb0360","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neulet.2017.09.065","article-title":"Mitochondrial ROS-mediated post-transcriptional regulation of \u03b1-synuclein through miR-7 and miR-153","volume":"661","author":"Je","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.exger.2021.111585_bb0365","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2005.01.014","article-title":"RAS is regulated by the let-7 microRNA family","volume":"120","author":"Johnson","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.exger.2021.111585_bb0370","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.nbd.2017.04.014","article-title":"Drosophila PINK1 and parkin loss-of-function mutants display a range of non-motor Parkinson\u2019s disease phenotypes","volume":"104","author":"Julienne","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.exger.2021.111585_bb0375","doi-asserted-by":"crossref","first-page":"13052","DOI":"10.1073\/pnas.0906277106","article-title":"Repression of alpha-synuclein expression and toxicity by microRNA-7","volume":"106","author":"Junn","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exger.2021.111585_bb0380","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.febslet.2014.12.014","article-title":"Inhibition of miR-34b and miR-34c enhances alpha-synuclein expression in Parkinson\u2019s disease","volume":"589","author":"Kabaria","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.exger.2021.111585_bb0385","first-page":"11284","article-title":"microRNA regulation of the embryonic hypoxic response in Caenorhabditis elegans","volume":"5","author":"Kagias","year":"2015","journal-title":"Nat. Publ. Group"},{"key":"10.1016\/j.exger.2021.111585_bb0390","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrd2031","article-title":"Finding function in novel targets: C. elegans as a model organism","volume":"5","author":"Kaletta","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.exger.2021.111585_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105028","article-title":"Microglia and astrocyte dysfunction in parkinson\u2019s disease","volume":"144","author":"Kam","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.exger.2021.111585_bb0400","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1261\/rna.2714411","article-title":"Age-associated changes in expression of small, noncoding RNAs, including microRNAs, in C. elegans","volume":"17","author":"Kato","year":"2011","journal-title":"RNA (New York, NY)"},{"key":"10.1016\/j.exger.2021.111585_bb0405","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature08980","article-title":"The genetics of ageing","volume":"464","author":"Kenyon","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.exger.2021.111585_bb0410","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/366461a0","article-title":"A C. elegans mutant that lives twice as long as wild type","volume":"366","author":"Kenyon","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.exger.2021.111585_bb0415","first-page":"321","article-title":"Plasma-based circulating MicroRNA biomarkers for Parkinson\u2019s disease","volume":"2","author":"Khoo","year":"2012","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.exger.2021.111585_bb0420","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1126\/science.1140481","article-title":"A MicroRNA feedback circuit in midbrain dopamine neurons","volume":"317","author":"Kim","year":"2007","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.exger.2021.111585_bb0425","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1126\/science.277.5328.942","article-title":"Daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans","volume":"277","author":"Kimura","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.exger.2021.111585_bb0430","doi-asserted-by":"crossref","first-page":"11654","DOI":"10.1523\/JNEUROSCI.4527-15.2016","article-title":"A drosophila model of neuronopathic gaucher disease demonstrates lysosomal-autophagic defects and altered mTOR signalling and is functionally rescued by rapamycin","volume":"36","author":"Kinghorn","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.exger.2021.111585_bb0435","doi-asserted-by":"crossref","first-page":"a008888","DOI":"10.1101\/cshperspect.a008888","article-title":"Genetics of Parkinson\u2019s disease","volume":"2","author":"Klein","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.exger.2021.111585_bb0440","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1042\/BST20180462","article-title":"LRRK2 links genetic and sporadic Parkinson\u2019s disease","volume":"47","author":"Kluss","year":"2019","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.exger.2021.111585_bb0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137432","article-title":"High throughput sequencing identifies MicroRNAs mediating \u03b1-synuclein toxicity by targeting neuroactive-ligand receptor interaction pathway in early stage of drosophila Parkinson\u2019s disease model","volume":"10","author":"Kong","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.exger.2021.111585_bb0450","doi-asserted-by":"crossref","first-page":"D152","DOI":"10.1093\/nar\/gkq1027","article-title":"miRBase: integrating microRNA annotation and deep-sequencing data","volume":"39","author":"Kozomara","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.exger.2021.111585_bb0455","first-page":"gky1141-","article-title":"miRBase: from microRNA sequences to function","volume":"47","author":"Kozomara","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.exger.2021.111585_bb0460","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1471-4159.2003.01809.x","article-title":"Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human alpha-synuclein","volume":"86","author":"Lakso","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.exger.2021.111585_bb0465","doi-asserted-by":"crossref","first-page":"7660","DOI":"10.18632\/aging.103028","article-title":"HOTAIR drives autophagy in midbrain dopaminergic neurons in the substantia nigra compacta in a mouse model of Parkinson\u2019s disease by elevating NPTX2 via miR-221-3p binding","volume":"12","author":"Lang","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.exger.2021.111585_bb0470","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.exger.2021.111585_bb0475","doi-asserted-by":"crossref","first-page":"16959","DOI":"10.1523\/JNEUROSCI.1807-10.2010","article-title":"LRRK2 kinase regulates synaptic morphology through distinct substrates at the presynaptic and postsynaptic compartments of the drosophila neuromuscular junction","volume":"30","author":"Lee","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.exger.2021.111585_bb0480","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.cub.2010.11.015","article-title":"MicroRNAs both promote and antagonize longevity in C. elegans","volume":"20","author":"de Lencastre","year":"2010","journal-title":"Curr. Biol."},{"key":"10.1016\/j.exger.2021.111585_bb0485","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.molcel.2010.09.027","article-title":"MicroRNA functions in stress responses","volume":"40","author":"Leung","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.exger.2021.111585_bb0490","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s12031-017-0994-x","article-title":"Let-7d microRNA attenuates 6-OHDA-induced injury by targeting Caspase-3 in MN9D cells","volume":"63","author":"Li","year":"2017","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.exger.2021.111585_bb0495","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1080\/15476286.2018.1445959","article-title":"Anti-miRNA oligonucleotides: a comprehensive guide for design","volume":"15","author":"Lima","year":"2018","journal-title":"RNA Biol."},{"key":"10.1016\/j.exger.2021.111585_bb0500","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1073\/pnas.0708452105","article-title":"A drosophila model for LRRK2-linked parkinsonism","volume":"105","author":"Liu","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.exger.2021.111585_bb0505","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature10810","article-title":"The microRNA miR-34 modulates ageing and neurodegeneration in drosophila","volume":"482","author":"Liu","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.exger.2021.111585_bb0510","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.922032","article-title":"Overexpression of MicroRNA-133a inhibits apoptosis and autophagy in a cell model of Parkinson\u2019s disease by downregulating ras-related C3 botulinum toxin substrate 1 (RAC1)","volume":"26","author":"Lu","year":"2020","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.exger.2021.111585_bb0515","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/cbf.3224","article-title":"Serum miR-221 serves as a biomarker for Parkinson\u2019s disease","volume":"34","author":"Ma","year":"2016","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.exger.2021.111585_bb0520","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.brainresbull.2020.10.019","article-title":"Up-regulated microRNA-218-5p ameliorates the damage of dopaminergic neurons in rats with Parkinson\u2019s disease via suppression of LASP1","volume":"166","author":"Ma","year":"2021","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.exger.2021.111585_bb0525","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2174\/138920209788185225","article-title":"Epigenetic control of MicroRNA expression and aging","volume":"10","author":"Macfarlane","year":"2009","journal-title":"Curr. Genomics"},{"key":"10.1016\/j.exger.2021.111585_bb0530","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1073\/pnas.1913904117","article-title":"The process of lewy body formation, rather than simply \u03b1-synuclein fibrillization, is one of the major drivers of neurodegeneration","volume":"117","author":"Mahul-Mellier","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.exger.2021.111585_bb0535","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jbiotec.2011.01.023","article-title":"Identification of blood microRNAs associated to Parkinso\u0144s disease","volume":"152","author":"Margis","year":"2011","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.exger.2021.111585_bb0540","doi-asserted-by":"crossref","first-page":"16268","DOI":"10.1073\/pnas.1002696107","article-title":"Insulin-like growth factor 1 treatment extends longevity in a mouse model of human premature aging by restoring somatotroph axis function","volume":"107","author":"Mari\u00f1o","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exger.2021.111585_bb0545","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.gde.2017.02.011","article-title":"C. elegans as a model system to accelerate discovery for parkinson disease","volume":"44","author":"Martinez","year":"2017","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.exger.2021.111585_bb0550","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025443","article-title":"Convergence of miRNA expression profiling, \u03b1-synuclein interacton and GWAS in Parkinson\u2019s disease","volume":"6","author":"Martins","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.exger.2021.111585_bb0555","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher disease glucocerebrosidase and \u03b1-synuclein form a bidirectional pathogenic loop in synucleinopathies","volume":"146","author":"Mazzulli","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.exger.2021.111585_bb0560","doi-asserted-by":"crossref","DOI":"10.1126\/science.aav1741","article-title":"The biochemical basis of microRNA targeting efficacy","volume":"366","author":"McGeary","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.exger.2021.111585_bb0565","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40478-020-0894-0","article-title":"Early-onset impairment of the ubiquitin-proteasome system in dopaminergic neurons caused by \u03b1-synuclein","volume":"8","author":"McKinnon","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.exger.2021.111585_bb0570","article-title":"Analysis of the micro-RNA-133and PITX3genes in Parkinson\u2019s disease","volume":"9999B","author":"de Mena","year":"2010","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.exger.2021.111585_bb0575","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.cub.2005.07.064","article-title":"Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson\u2019s disease","volume":"15","author":"Meulener","year":"2005","journal-title":"Curr. Biol."},{"key":"10.1016\/j.exger.2021.111585_bb0580","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/hmg\/ddr210","article-title":"MicroRNA profiling of Parkinson\u2019s disease brains identifies early downregulation of miR-34b\/c which modulate mitochondrial function","volume":"20","author":"Minones-Moyano","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.exger.2021.111585_bb0585","article-title":"\u03b1-synuclein transgenic drosophila as a model of Parkinson\u2019s disease and related synucleinopathies","volume":"2011","author":"Mizuno","year":"2010","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.exger.2021.111585_bb0590","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/bmb\/ldv022","article-title":"The genetics of Parkinson\u2019s disease","volume":"114","author":"Mullin","year":"2015","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.exger.2021.111585_bb0595","doi-asserted-by":"crossref","first-page":"16958","DOI":"10.1021\/ja505986a","article-title":"Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing","volume":"136","author":"Nair","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.exger.2021.111585_bb0600","article-title":"Mitochondrial quality control mediated by PINK1 and parkin: links to parkinsonism","volume":"4","author":"Narendra","year":"2012","journal-title":"Csh Perspect. Biol."},{"key":"10.1016\/j.exger.2021.111585_bb0605","doi-asserted-by":"crossref","first-page":"8866","DOI":"10.1038\/srep08866","article-title":"Specific microRNAs regulate heat stress responses in Caenorhabditis elegans","volume":"5","author":"Nehammer","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exger.2021.111585_bb0610","doi-asserted-by":"crossref","first-page":"R741","DOI":"10.1016\/j.cub.2012.07.024","article-title":"Ageing as a risk factor for disease review","volume":"22","author":"Niccoli","year":"2012","journal-title":"Curr. Biol."},{"key":"10.1016\/j.exger.2021.111585_bb0615","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.redox.2018.07.021","article-title":"The Parkinson\u2019s disease gene product DJ-1 modulates miR-221 to promote neuronal survival against oxidative stress","volume":"19","author":"Oh","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.exger.2021.111585_bb0620","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.neuro.22.1.123","article-title":"Etiology and pathogenesis of Parkinson\u2019s disease","volume":"22","author":"Olanow","year":"1999","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.exger.2021.111585_bb0625","doi-asserted-by":"crossref","first-page":"11869","DOI":"10.1038\/s41598-020-68808-3","article-title":"Classification of \u03b1-synuclein-induced changes in the AAV \u03b1-synuclein rat model of Parkinson\u2019s disease using electrophysiological measurements of visual processing","volume":"10","author":"\u00d8stergaard","year":"2020","journal-title":"Sci. Rep.-UK"},{"key":"10.1016\/j.exger.2021.111585_bb0630","doi-asserted-by":"crossref","first-page":"14341","DOI":"10.1523\/JNEUROSCI.2390-08.2008","article-title":"The bifunctional microRNA miR-9\/miR-9* regulates REST and CoREST and is downregulated in Huntington\u2019s disease","volume":"28","author":"Packer","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.exger.2021.111585_bb0635","doi-asserted-by":"crossref","first-page":"18614","DOI":"10.1074\/jbc.M401135200","article-title":"Mitochondrial dysfunction and oxidative damage in parkin-deficient Mice*","volume":"279","author":"Palacino","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exger.2021.111585_bb0640","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/nature04788","article-title":"Mitochondrial dysfunction in drosophila PINK1 mutants is complemented by parkin","volume":"441","author":"Park","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.exger.2021.111585_bb0645","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/mds.25772","article-title":"Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson\u2019s disease","volume":"29","author":"Parnetti","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.exger.2021.111585_bb0650","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143969","article-title":"A proteomics approach to investigate miR-153-3p and miR-205-5p targets in neuroblastoma cells","volume":"10","author":"Patil","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.exger.2021.111585_bb0655","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpls.2015.00232","article-title":"miRNA regulation of nutrient homeostasis in plants","volume":"06","author":"Paul","year":"2015","journal-title":"Front. Plant Sci."},{"key":"10.1016\/j.exger.2021.111585_bb0660","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3390\/brainsci10020119","article-title":"Management of neuroinflammatory responses to AAV-mediated gene therapies for neurodegenerative diseases","volume":"10","author":"Perez","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.exger.2021.111585_bb0665","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mcn.2014.08.002","article-title":"Linking alpha-synuclein phosphorylation to reactive oxygen species formation and mitochondrial dysfunction in SH-SY5Y cells","volume":"62","author":"Perfeito","year":"2014","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.exger.2021.111585_bb0670","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002306","article-title":"MicroRNA predictors of longevity in Caenorhabditis elegans","volume":"7","author":"Pincus","year":"2011","journal-title":"PLoS Genet."},{"key":"10.1016\/j.exger.2021.111585_bb0675","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.tcb.2008.11.002","article-title":"Integrating the stress response: lessons for neurodegenerative diseases from C. elegans","volume":"19","author":"Prahlad","year":"2009","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.exger.2021.111585_bb0680","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/mds.25945","article-title":"The prevalence of Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"29","author":"Pringsheim","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.exger.2021.111585_bb0685","doi-asserted-by":"crossref","first-page":"E4929","DOI":"10.1073\/pnas.1503911112","article-title":"Transcription factors FOXA1 and FOXA2 maintain dopaminergic neuronal properties and control feeding behavior in adult mice","volume":"112","author":"Prister\u00e0","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.exger.2021.111585_bb0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2019.111614","article-title":"Downregulated lncRNA-SNHG1 enhances autophagy and prevents cell death through the miR-221\/222\/p27\/mTOR pathway in Parkinson\u2019s disease","volume":"384","author":"Qian","year":"2019","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.exger.2021.111585_bb0695","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/mds.27928","article-title":"Circulating brain-enriched MicroRNAs for detection and discrimination of idiopathic and genetic Parkinson\u2019s disease","volume":"35","author":"Ravanidis","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.exger.2021.111585_bb0700","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/35002607","article-title":"The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans","volume":"403","author":"Reinhart","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.exger.2021.111585_bb0705","first-page":"5","article-title":"Time dependent degeneration of the nigrostriatal tract in mice with 6-OHDA lesioned medial forebrain bundle and the effect of activin a on L-dopa induced dyskinesia","author":"Rentsch","year":"2020","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.exger.2021.111585_bb0710","first-page":"215","article-title":"Neuronal expression of familial Parkinson\u2019s disease A53T \u03b1-synuclein causes early motor impairment, reduced anxiety and potential sleep disturbances in mice","volume":"3","author":"Rothman","year":"2013","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.exger.2021.111585_bb0715","first-page":"1","article-title":"Perspectives on C. elegans models of human Parkinson\u2019s Disease","volume":"3","author":"Rudgalvyte","year":"2015"},{"key":"10.1016\/j.exger.2021.111585_bb0720","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2013.65","article-title":"Lipid nanoparticle delivery of siRNA to silence neuronal gene expression in the brain","volume":"2","author":"Rungta","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.exger.2021.111585_bb0725","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1523\/JNEUROSCI.4810-06.2007","article-title":"A drosophila model of mutant human parkin-induced toxicity demonstrates selective loss of dopaminergic neurons and dependence on cellular dopamine","volume":"27","author":"Sang","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.exger.2021.111585_bb0730","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1084\/jem.20070823","article-title":"Cerebellar neurodegeneration in the absence of microRNAs","volume":"204","author":"Schaefer","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.exger.2021.111585_bb0735","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/mds.23732","article-title":"Etiology and pathogenesis of Parkinson\u2019s disease","volume":"26","author":"Schapira","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.exger.2021.111585_bb0740","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial complex I deficiency in Parkinson\u2019s disease","volume":"54","author":"Schapira","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.exger.2021.111585_bb0745","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/j.neurobiolaging.2014.03.016","article-title":"Orchestrated increase of dopamine and PARK mRNAs but not miR-133b in dopamine neurons in Parkinson\u2019s disease","volume":"35","author":"Schlaudraff","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.exger.2021.111585_bb0750","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","article-title":"Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes","volume":"22","author":"Shahmoradian","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.exger.2021.111585_bb0755","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3164\/jcbn.18-25","article-title":"Modification of \u03b1-synuclein by lipid peroxidation products derived from polyunsaturated fatty acids promotes toxic oligomerization: its relevance to parkinson disease","volume":"62","author":"Shamoto-Nagai","year":"2018","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.exger.2021.111585_bb0760","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1007\/s12035-015-9145-y","article-title":"Role of MicroRNA Let-7 in modulating multifactorial aspect of neurodegenerative diseases: an overview","volume":"53","author":"Shamsuzzama","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.exger.2021.111585_bb0765","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3389\/fnmol.2017.00328","article-title":"Modulation of alpha-synuclein expression and associated effects by MicroRNA Let-7 in Transgenic C. elegans","volume":"10","author":"Shamsuzzama","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.exger.2021.111585_bb0770","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.67604","article-title":"Pharmacological rescue of impaired mitophagy in Parkinson\u2019s disease-related LRRK2 G2019S knock-in mice","volume":"10","author":"Singh","year":"2021","journal-title":"elife"},{"key":"10.1016\/j.exger.2021.111585_bb0775","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"\u03b1-synuclein locus triplication causes Parkinson9s disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.exger.2021.111585_bb0780","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1242\/jcs.099200","article-title":"MicroRNAs and their roles in aging","volume":"125","author":"Smith-Vikos","year":"2012","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.exger.2021.111585_bb0785","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3390\/cells7120245","article-title":"Exploring MicroRNA biomarkers for Parkinson\u2019s disease from mRNA expression profiles","volume":"7","author":"Taguchi","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.exger.2021.111585_bb0790","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0304-3940(02)01258-2","article-title":"Phosphorylation of \u03b1-synuclein characteristic of synucleinopathy lesions is recapitulated in \u03b1-synuclein transgenic drosophila","volume":"336","author":"Takahashi","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.exger.2021.111585_bb0795","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s12035-014-8803-9","article-title":"Causes and consequences of MicroRNA dysregulation in neurodegenerative diseases","volume":"51","author":"Tan","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.exger.2021.111585_bb0800","doi-asserted-by":"crossref","first-page":"10613","DOI":"10.1523\/JNEUROSCI.0042-15.2015","article-title":"VPS35 in dopamine neurons is required for endosome-to-golgi retrieval of Lamp2a, a receptor of chaperone-mediated autophagy that is critical for \u03b1-synuclein degradation and prevention of pathogenesis of Parkinson\u2019s disease","volume":"35","author":"Tang","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.exger.2021.111585_bb0805","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2010.03.004","article-title":"Behavioral phenotyping of mouse models of Parkinson\u2019s disease","volume":"211","author":"Taylor","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.exger.2021.111585_bb0810","doi-asserted-by":"crossref","first-page":"E8284","DOI":"10.1073\/pnas.1710442114","article-title":"Modeling Parkinson\u2019s disease pathology by combination of fibril seeds and \u03b1-synuclein overexpression in the rat brain","volume":"114","author":"Thakur","year":"2017","journal-title":"Proc National Acad Sci"},{"key":"10.1016\/j.exger.2021.111585_bb0815","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1523\/JNEUROSCI.3900-15.2016","article-title":"MicroRNA-155 regulates alpha-synuclein-induced inflammatory responses in models of parkinson disease","volume":"36","author":"Thome","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.exger.2021.111585_bb0820","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.neurobiolaging.2018.05.032","article-title":"MicroRNA alterations in iPSC-derived dopaminergic neurons from parkinson disease patients","volume":"69","author":"Tolosa","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.exger.2021.111585_bb0825","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3389\/fneur.2018.00860","article-title":"Outside in: unraveling the role of neuroinflammation in the progression of Parkinson\u2019s Disease","volume":"9","author":"Troncoso-Escudero","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.exger.2021.111585_bb0830","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1093\/hmg\/ddu178","article-title":"Parkinson\u2019s disease-linked mutations in VPS35 induce dopaminergic neurodegeneration","volume":"23","author":"Tsika","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.exger.2021.111585_bb0835","doi-asserted-by":"crossref","first-page":"16010","DOI":"10.1038\/npjamd.2016.10","article-title":"Lifespan-regulating genes in C. elegans","volume":"2","author":"Uno","year":"2016","journal-title":"NPJ Aging Mech.\u202fDis."},{"key":"10.1016\/j.exger.2021.111585_bb0840","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.celrep.2016.12.023","article-title":"Synucleins have multiple effects on presynaptic architecture","volume":"18","author":"Vargas","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.exger.2021.111585_bb0845","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neulet.2018.10.040","article-title":"Up-regulation of protective neuronal MicroRNAs by FTY720 and novel FTY720-derivatives","volume":"690","author":"Vargas-Medrano","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.exger.2021.111585_bb0850","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jneumeth.2015.07.025","article-title":"\u03b1-synuclein and nonhuman primate models of Parkinson\u2019s disease","volume":"255","author":"Vermilyea","year":"2015","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.exger.2021.111585_bb0855","first-page":"11","article-title":"C. elegans as a genetic model system to identify Parkinson\u2019s disease-associated therapeutic targeets","author":"Vistbakka","year":"2012","journal-title":"CNS Neurol. Disord."},{"key":"10.1016\/j.exger.2021.111585_bb0860","first-page":"1231","article-title":"MicroRNAs: synthesis, mechanism, function, and recent clinical trials","volume":"1803","author":"Wahid","year":"2010","journal-title":"BBA-Mol. Cell. Res."},{"key":"10.1016\/j.exger.2021.111585_bb0865","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.tibs.2011.06.002","article-title":"miRNA response to DNA damage","volume":"36","author":"Wan","year":"2011","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.exger.2021.111585_bb0870","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4161\/cc.23051","article-title":"MicroRNAs and DNA damage response","volume":"12","author":"Wang","year":"2013","journal-title":"Cell Cycle (Georgetown, Tex)"},{"key":"10.1016\/j.exger.2021.111585_bb0875","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ajhg.2007.09.021","article-title":"Variation in the miRNA-433 binding site of FGF20 confers risk for parkinson disease by overexpression of \u03b1-synuclein","volume":"82","author":"Wang","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.exger.2021.111585_bb0880","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.3390\/cells9092022","article-title":"Ubiquitin, autophagy and neurodegenerative diseases","volume":"9","author":"Watanabe","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.exger.2021.111585_bb0885","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2016.00129","article-title":"Getting miRNA therapeutics into the target cells for neurodegenerative diseases: a mini-review ed. H. Soreq","volume":"9","author":"Wen","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.exger.2021.111585_bb0890","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/381281","article-title":"Neurophysiology of DrosophilaModels of Parkinson\u2019s disease","volume":"2015","author":"West","year":"2015","journal-title":"Parkinson\u2019s Dis."},{"key":"10.1016\/j.exger.2021.111585_bb0895","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1083\/jcb.201003122","article-title":"\u03b1-synuclein impairs macroautophagy: implications for Parkinson\u2019s disease","volume":"190","author":"Winslow","year":"2010","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.exger.2021.111585_bb0900","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.mrfmmm.2011.03.012","article-title":"MicroRNAs, the DNA damage response and cancer","volume":"717","author":"Wouters","year":"2011","journal-title":"Mutat. Res."},{"issue":"4","key":"10.1016\/j.exger.2021.111585_bb0905","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1159\/000495649","article-title":"Inhibition of microRNA-200a upregulates the expression of striatal dopamine receptor D2 to repress apoptosis of striatum via the cAMP\/PKA signaling pathway in rats with Parkinson\u2019s Disease","volume":"51","author":"Wu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.exger.2021.111585_bb0910","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135602","article-title":"SOX21-AS1 modulates neuronal injury of MMP+-treated SH-SY5Y cells via targeting miR-7-5p and inhibiting IRS2","volume":"746","author":"Xie","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.exger.2021.111585_bb0915","doi-asserted-by":"crossref","first-page":"201712648","DOI":"10.1073\/pnas.1712648115","article-title":"Robust kinase- and age-dependent dopaminergic and norepinephrine neurodegeneration in LRRK2 G2019S transgenic mice","volume":"115","author":"Xiong","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.exger.2021.111585_bb0920","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S0960-9822(03)00250-1","article-title":"The drosophila MicroRNA Mir-14 suppresses cell death and is required for Normal fat metabolism","volume":"13","author":"Xu","year":"2003","journal-title":"Curr. Biol."},{"key":"10.1016\/j.exger.2021.111585_bb0925","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11357-011-9324-3","article-title":"MiR-34 modulates Caenorhabditis elegans lifespan via repressing the autophagy gene atg9","volume":"35","author":"Yang","year":"2013","journal-title":"AGE"},{"key":"10.1016\/j.exger.2021.111585_bb0930","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.addr.2020.07.022","article-title":"Recent advances in siRNA delivery mediated by lipid-based nanoparticles","volume":"154\u2013155","author":"Yonezawa","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.exger.2021.111585_bb0935","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/aps.2017.49","article-title":"Reassessment of subacute MPTP-treated mice as animal model of Parkinson\u2019s disease","volume":"38","author":"Zhang","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.exger.2021.111585_bb0940","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fncel.2017.00170","article-title":"Reduced circulating levels of miR-433 and miR-133b are potential biomarkers for Parkinson\u2019s disease","volume":"11","author":"Zhang","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.exger.2021.111585_bb0945","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-1-4939-9124-2_5","article-title":"Alpha-synuclein, methods and protocols","volume":"1948","author":"Zhang","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.exger.2021.111585_bb0950","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.bbrc.2019.08.140","article-title":"miR-let-7a suppresses \u03b1-synuclein-induced microglia inflammation through targeting STAT3 in Parkinson\u2019s disease","volume":"519","author":"Zhang","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.exger.2021.111585_bb0955","series-title":"Downregulation of long noncoding RNA SNHG7 protects against inflammation and apoptosis in Parkinson\u2019s disease model by targeting the miR-425-5p\/TRAF5\/NF-\u03baB axis","author":"Zhang","year":"2021"},{"key":"10.1016\/j.exger.2021.111585_bb0960","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40659-019-0267-y","article-title":"SNHG1 promotes MPP+-induced cytotoxicity by regulating PTEN\/AKT\/mTOR signaling pathway in SH-SY5Y cells via sponging miR-153-3p","volume":"53","author":"Zhao","year":"2020","journal-title":"Biol. Res."},{"key":"10.1016\/j.exger.2021.111585_bb0965","first-page":"4179","article-title":"Overexpression of miR-153 promotes oxidative stress in MPP+-induced PD model by negatively regulating the Nrf2\/HO-1 signaling pathway","volume":"11","author":"Zhu","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.exger.2021.111585_bb0970","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41419-020-2322-6","article-title":"Pharmacological enhancement of TFEB-mediated autophagy alleviated neuronal death in oxidative stress-induced Parkinson\u2019s disease models","volume":"11","author":"Zhuang","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.exger.2021.111585_bb0975","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1038\/emboj.2011.327","article-title":"microRNA-34c is a novel target to treat dementias","volume":"30","author":"Zovoilis","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.exger.2021.111585_bb0980","doi-asserted-by":"crossref","first-page":"6972","DOI":"10.1523\/JNEUROSCI.4278-06.2007","article-title":"Widespread disruption of repressor Element-1 silencing transcription Factor\/Neuron-restrictive silencer factor occupancy at its target genes in Huntington\u2019s disease","volume":"27","author":"Zuccato","year":"2007","journal-title":"J. Neurosci."}],"container-title":["Experimental Gerontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556521003673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556521003673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T03:33:57Z","timestamp":1759980837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0531556521003673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":196,"alternative-id":["S0531556521003673"],"URL":"https:\/\/doi.org\/10.1016\/j.exger.2021.111585","relation":{},"ISSN":["0531-5565"],"issn-type":[{"value":"0531-5565","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parkinson's disease and microRNAs - Lessons from model organisms and human studies","name":"articletitle","label":"Article Title"},{"value":"Experimental Gerontology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exger.2021.111585","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111585"}}